Article PDF
References
Lavie, A. et al. The bottleneck in AZT activation. Nature Med. 3, 922–924 (1997).
Balzarini, J. et al. The in vitro and in vivo anti-retro-virus activity, and intracellular metabolism of 3′-azido-2′,3′-dideoxythymidine and 2′,3′-dideoxy-cytidine are highly dependent on the cell species. Biochem. Pharmacol. 37, 897–903 (1988).
Balzarini, J., Herdewijn, P. & De Clercq, E. Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J. Biol. Chem. 264, 6127–6133 (1989).
Frick, L.W. et al. Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Comm. 154, 124–129 (1988).
Guettari, N., Loubiere, L., Brisson, E. & Klatzmann, D. Use of Herpes-simplex Virus Thymidine Kinase to Imporve the Antiviral Activity of Zidovudine. Virology 235, 398–405 (1997).
Meier, C., Habel, L., Laux, W., Declercq, E., & Balzarini, J. Homo Dinucleoside-alpha-hydroxyphosphonate Diesters as Prodrugs of the Antiviral Nucleoside Analogues 2′,3′-Dideoxythymidine and 3′-Azido-2′,3′Dideoxythymidine. Nudeosides & Nudeotides 14, 759–762 (1995).
Lavie, A. et al. Crystal Structure of Yeast Thymidylate Kinase Complexed with the Bisubstrate Inhibitor P1-(5′-Adenosyl)P5-(5′-Thymidyl)Pentaphosphate (TP5A) at 2.0 Å Resolution: Implications for Catalysis and AZT Activation Biochem. In the press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lavie, A., Reinstein, J., Goody, R. et al. Reply to “Improving AZT efficacy”. Nat Med 4, 132 (1998). https://doi.org/10.1038/nm0298-132b
Issue Date:
DOI: https://doi.org/10.1038/nm0298-132b